New drug may keep T-Cell lymphoma at bay after transplant
Disease control
Recruiting now
This study tests whether the drug ruxolitinib, taken as a maintenance therapy after a stem cell transplant, can help prevent the lymphoma from coming back and reduce the risk of graft-versus-host disease (GVHD), a common complication where donor cells attack the patient's body. A…
Phase: PHASE2 • Sponsor: Jonathan Brammer • Aim: Disease control
Last updated Jun 12, 2026 12:16 UTC